ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 95 filers reported holding ATHIRA PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,240,000 | -19.8% | 240,030 | -22.6% | 1.51% | -10.8% |
| Q4 2021 | $4,040,000 | +44.9% | 310,030 | +4.3% | 1.70% | +72.6% |
| Q3 2021 | $2,789,000 | -36.2% | 297,362 | -30.4% | 0.98% | -43.7% |
| Q2 2021 | $4,373,000 | -40.6% | 427,060 | +6.8% | 1.75% | -34.1% |
| Q1 2021 | $7,360,000 | -45.3% | 400,000 | +1.8% | 2.65% | -27.5% |
| Q4 2020 | $13,460,000 | +101.1% | 393,000 | +8.4% | 3.66% | +101.6% |
| Q3 2020 | $6,692,000 | – | 362,500 | – | 1.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,630,744 | $21,249,000 | 2.19% |
| VR Adviser, LLC | 1,000,000 | $13,030,000 | 1.78% |
| ACUTA CAPITAL PARTNERS, LLC | 310,030 | $4,040,000 | 1.70% |
| Ikarian Capital, LLC | 860,000 | $11,207,000 | 1.67% |
| Bristlecone Advisors, LLC | 761,563 | $9,923,000 | 1.19% |
| Perceptive Advisors | 6,851,832 | $89,280,000 | 0.69% |
| DAFNA Capital Management LLC | 160,983 | $2,098,000 | 0.53% |
| PATHSTONE FAMILY OFFICE, LLC | 1,442,247 | $18,792,000 | 0.47% |
| Potomac Capital Management, Inc. | 40,000 | $521,000 | 0.46% |
| RTW INVESTMENTS, LP | 1,906,557 | $24,842,000 | 0.36% |